Baxter highlights advances clinical nutrition

Baxter International Inc. has recently launched Clinolipid (20 percent Lipid Injectable Emulsion), its proprietary olive oil-based lipid emulsion, in the U.S. – marking the growth of Baxter’s lipid portfolio. The announcement was made at the 2019 ASPEN Nutrition Science & Practice Conference, where Baxter featured its diverse portfolio of parenteral nutrition (PN) products to focus on, and help improve care for malnourished patients. For patients who cannot maintain a sufficient source of calories orally or enterally, such as critically ill patients and those who have undergone major surgery, PN is prescribed as an intravenous administration of nourishment. PN may include proteins, carbohydrates, fats, electrolytes, vitamins, and other trace elements, and plays a critical role in helping reduce malnutrition and achieve stronger health outcomes.